Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/j.1399-3062.2012.00773.x http://scihub22266oqcxt.onion/10.1111/j.1399-3062.2012.00773.x 22931551!ä!22931551 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Transpl+Infect+Dis 2012 ; 14 (5): E64-70 Nephropedia Template TP {{tp|p=22931551|t=2012. How many times can parvovirus B19-related anemia recur in solid organ transplant recipients?|pdf=|usr=}}{{22931551}} gab.com Text How many times can parvovirus B19-related anemia recur in solid organ transplant recipients JO: Transpl Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=22931551 #FOAvip Parvovirus B19 (PB19) infection is known to cause acute erythroblastopenia-mediated anemia in solid organ transplant (SOT) recipients. Intravenous immunoglobulins (IVIg) and the decrease of immunosuppression level are supposed to induce a long-term remission, although no consensus exists about the dose and the schedule of IVIg administrations. However, a few reports have shown that PB19-related anemia can recur despite this treatment, with a maximum of 3 recurrences reported. In this report, we describe in detail the cases of 2 kidney recipients with PB19 infection. They experienced, respectively, 9 and 7 PB19-related anemia recurrences. Immunosuppression level was decreased and IVIg were administered at each recurrence followed by a transitory normalization of hemoglobin level and a decrease of serum PB19 viral load. Episodes were separated by several months. These patients raise an original therapeutic management question about a frequent viral infection in SOT recipients. One patient is currently receiving IVIg every 3 months as a secondary prophylaxis without recurrence to date. These 2 case reports are followed by a review of the literature. Twit Text FOAVip How many times can parvovirus B19-related anemia recur in solid organ transplant recipients ????Transpl Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=22931551 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=22931551 #FOAvip English Wikipedia <ref>{{Cite pmid|22931551}}</ref> How many times can parvovirus B19-related anemia recur in solid organ transplant recipients? #MMPMID22931551 Gosset C; Viglietti D; Hue K; Antoine C; Glotz D; Pillebout E Transpl Infect Dis 2012[Oct]; 14 (5): E64-70 PMID22931551show ga Parvovirus B19 (PB19) infection is known to cause acute erythroblastopenia-mediated anemia in solid organ transplant (SOT) recipients. Intravenous immunoglobulins (IVIg) and the decrease of immunosuppression level are supposed to induce a long-term remission, although no consensus exists about the dose and the schedule of IVIg administrations. However, a few reports have shown that PB19-related anemia can recur despite this treatment, with a maximum of 3 recurrences reported. In this report, we describe in detail the cases of 2 kidney recipients with PB19 infection. They experienced, respectively, 9 and 7 PB19-related anemia recurrences. Immunosuppression level was decreased and IVIg were administered at each recurrence followed by a transitory normalization of hemoglobin level and a decrease of serum PB19 viral load. Episodes were separated by several months. These patients raise an original therapeutic management question about a frequent viral infection in SOT recipients. One patient is currently receiving IVIg every 3 months as a secondary prophylaxis without recurrence to date. These 2 case reports are followed by a review of the literature. |Adult[MESH] |Anemia/*etiology/prevention & control[MESH] |Humans[MESH] |Immunoglobulins, Intravenous/therapeutic use[MESH] |Kidney Transplantation/*adverse effects[MESH] |Male[MESH] |Parvoviridae Infections/*complications/*virology[MESH] |Parvovirus B19, Human/*isolation & purification[MESH]How many times can parvovirus B19-related anemia recur in solid organ (epmc).pdf DeepDyve Pubget Overpricing